TFP Block vs ESPB for Inguinal Hernia Repair Post-operative Analgesia
This study aims to compare the effectiveness of TFP Block and ESPB for reducing post-operative pain intensity in individuals undergoing inguinal hernia repair, measured on a scale from 0 to 10.
Transversalis fascia plane (TFP) block
+ Erector Spinae Plane (ESP) Block
Neurologic Manifestations+4
+ Pain
+ Pain, Postoperative
Prevention Study
Summary
Study start date: December 1, 2022
Actual date on which the first participant was enrolled.This study focuses on improving pain management after inguinal hernia repair surgery, a common procedure worldwide. The goal is to find better ways to control post-operative pain, as unmanaged pain can lead to complications. The study compares two types of regional blocks, which are methods of pain control that target specific areas of the body. These are the Ultrasound-guided Transversalis Fascia Plane Block and the Erector Spinae Plane Block. Both methods involve injecting a local anesthetic into specific areas to block pain signals. The study aims to reduce reliance on opioid painkillers, which can cause side effects like itching, nausea, and breathing problems. During the study, participants receive one of the two types of blocks before their surgery. The Ultrasound-guided Transversalis Fascia Plane Block involves injecting the anesthetic between the transversus abdominis muscle and its deep investing fascia. The Erector Spinae Plane Block involves injecting the anesthetic between the erector spinae muscle and thoracic transverse process. The study measures the intensity of post-operative pain using a verbal scale from 0 to 10, with 0 representing no pain and 10 representing the worst possible pain.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.43 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Male
Biological sex of participants that are eligible to enroll.From 20 to 65 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
PlaceboGroup II
Active ComparatorStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location